ChatGPT-3 and 4 scored 65.1 and 62.4 percent on 455 questions from the 2022 and 2021 ACG Self-Assessment Tests<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, May 22, 2023 (HealthDay News) — The natural language processing model Chat Generative Pretrained Transformer (ChatGPT) does not pass the American College of Gastroenterology (ACG) Self-Assessment Tests, according to a study published online May 22 in the American Journal of Gastroenterology<\/em>.<\/p>\n Kelly Suchman, M.D., from the Zucker School of Medicine at Hofstra\/Northwell and the Long Island Jewish Medical Center in New Hyde Park, New York, and colleagues assessed ChatGPT-3 and ChatGPT-4 performance on the 2022 and 2021 ACG Self-Assessment Tests. A 70 percent score or higher was required to pass the assessment.<\/p>\n The researchers found that ChatGPT-3 and ChatGPT-4 scored 65.1 and 62.4 percent, respectively, on 455 included questions across the two exams.<\/p>\n “Recently, there has been a lot of attention on ChatGPT and the use of artificial intelligence across various industries. When it comes to medical education, there is a lack of research around this potential ground-breaking tool,” lead author Arvind Trindade, M.D., from the Feinstein Institutes for Medical Research in Manhasset, New York, said in a statement. “Based on our research, ChatGPT should not be used for medical education in gastroenterology at this time and has a ways to go before it should be implemented into the health care field.”<\/p>\n Two authors disclosed ties to the medical device and biotechnology industries.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n